BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34308862)

  • 1. [Analysis of brain perfusion single-photon emission tomography images using an easy Zscore imaging system for early diagnosis of Alzheimer's disease].
    Wang S; Qi Y; Jiang Y; Chi X; Huang K; Ruan C; Yang X; Li G
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1093-1100. PubMed ID: 34308862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
    Takemaru M; Kimura N; Abe Y; Goto M; Matsubara E
    Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    Tokumitsu K; Yasui-Furukori N; Takeuchi J; Yachimori K; Sugawara N; Terayama Y; Tanaka N; Naraoka T; Shimoda K
    PLoS One; 2021; 16(2):e0247427. PubMed ID: 33617587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparison with Chang's method.
    Sohara K; Kiriyama T; Mizumura S; Ishiwata A; Yamazaki M; Kimura K; Kumita SI
    Ann Nucl Med; 2020 Jul; 34(7):502-511. PubMed ID: 32449110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
    Waragai M; Mizumura S; Yamada T; Matsuda H
    Dement Geriatr Cogn Disord; 2008; 26(6):547-55. PubMed ID: 19066428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Cuberas-Borrós G; Vinyes-Junqué G; Espinosa A; Valero S; Hernández I; Roca I; Ruíz A; Rosende-Roca M; Mauleón A; Becker JT; Castell-Conesa J; Tárraga L; Boada M
    J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of MCI with Lewy bodies and MCI due to Alzheimer's disease by visual assessment of occipital hypoperfusion on SPECT images.
    Nakata T; Shimada K; Iba A; Oda H; Terashima A; Koide Y; Kawasaki R; Yamada T; Ishii K
    Jpn J Radiol; 2024 Mar; 42(3):308-318. PubMed ID: 37861956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An easy Z-score imaging system for discrimination between very early Alzheimer's disease and controls using brain perfusion SPECT in a multicentre study.
    Matsuda H; Mizumura S; Nagao T; Ota T; Iizuka T; Nemoto K; Kimura M; Tateno A; Ishiwata A; Kuji I; Arai H; Homma A
    Nucl Med Commun; 2007 Mar; 28(3):199-205. PubMed ID: 17264779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography.
    Matsuda H; Mizumura S; Nagao T; Ota T; Iizuka T; Nemoto K; Takemura N; Arai H; Homma A
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):731-6. PubMed ID: 17416830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Alzheimer's disease patients and healthy controls in the easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: verification using normal database of our institution.
    Ohba M; Kobayashi R; Kirii K; Fujita K; Kanezawa C; Hayashi H; Kawakatsu S; Otani K; Kanoto M; Suzuki K
    Ann Nucl Med; 2021 Mar; 35(3):307-313. PubMed ID: 33394329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic approach with Z-score mapping to reduce artifacts caused by cerebral atrophy in regional CBF assessment of mild cognitive impairment (MCI) and Alzheimer's disease by [
    Odano I; Maeyatsu F; Hosoya T; Asari M; Oba K; Taki Y
    Jpn J Radiol; 2024 May; 42(5):508-518. PubMed ID: 38351252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the decreases in regional cerebral blood flow in the posterior cingulate cortex, precuneus, and parietal lobe between suspected non-Alzheimer's disease pathophysiology and Alzheimer's disease.
    Hayashi H; Kobayashi R; Kawakatsu S; Ohba M; Morioka D; Otani K
    Psychogeriatrics; 2021 Sep; 21(5):716-721. PubMed ID: 34101304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W; Schönauer U; Zauner H; Spindler I; Mair A; Iglseder B; Bernroider G; Ladurner G
    J Neural Transm (Vienna); 2006 Feb; 113(2):195-203. PubMed ID: 15959843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.
    Rossini F; Zauner H; Bergmann J; Kronbichler M; Spindler I; Golaszewski S; Trinka E; Staffen W
    Curr Alzheimer Res; 2019; 16(9):843-851. PubMed ID: 31453786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.